Structural investigation of one‐ and two‐dimensional coordination polymers based on cobalt–bis(dioxolene) units and 1‐hydroxy‐1,2,4,5‐tetrakis(pyridin‐4‐yl)cyclohexane

The combination of cobalt, 3,5‐di‐tert‐butyldioxolene (3,5‐dbdiox) and 1‐hydroxy‐1,2,4,5‐tetrakis(pyridin‐4‐yl)cyclohexane (tpch) yields two coordination polymers with different connectivities, i.e. a one‐dimensional zigzag chain and a two‐dimensional sheet. Poly[[bis(3,5‐di‐tert‐butylbenzene‐1,2‐diolato)bis(1,5‐di‐tert‐butyl‐4‐oxocyclohexa‐2,5‐dien‐1‐yl‐3‐olato)[μ₄‐1‐hydroxy‐1,2,4,5‐tetrakis(pyridin‐4‐yl)cyclohexane]cobalt(III)]–ethanol–water 1/7/5], {[Co₂(C₁₄H₂₀O₂)₄(C₂₆H₂₄N₄O)]·7C₂H₅OH·5H₂O}_n or {[Co₂(3,5‐dbdiox)₄(tpch)}·7EtOH·5H₂O}_n, is the second structurally characterized example of a two‐dimensional coordination polymer based on linked {Co(3,5‐dbdiox)₂} units. Variable‐temperature single‐crystal X‐ray diffraction studies suggest that catena‐poly[[[(3,5‐di‐tert‐butylbenzene‐1,2‐diolato)(1,5‐di‐tert‐butyl‐4‐oxocyclohexa‐2,5‐dien‐1‐yl‐3‐olato)cobalt(III)]‐μ‐1‐hydroxy‐1,2,4,5‐tetrakis(pyridin‐4‐yl)cyclohexane]–ethanol–water (1/1/5)], {[Co(C₁₄H₂₀O₂)₂(C₂₆H₂₄N₄O)]·C₂H₅OH·5H₂O}_n or {[Co(3,5‐dbdiox)₂(tpch)]·EtOH·5H₂O}_n, undergoes a temperature‐induced valence tautomeric interconversion.     

Comparison of the hydrogen‐bond patterns in 2‐amino‐1,3,4‐thiadiazolium hydrogen oxalate, 2‐amino‐1,3,4‐thiadiazole–succinic acid (1/2), 2‐amino‐1,3,4‐thiadiazole–glutaric acid (1/1) and 2‐amino‐1,3,4‐thiadiazole–adipic acid (1/1)

The X‐ray single‐crystal structure determinations of the chemically related compounds 2‐amino‐1,3,4‐thiadiazolium hydrogen oxalate, C₂H₄N₃S⁺·C₂HO₄⁻, (I), 2‐amino‐1,3,4‐thiadiazole–succinic acid (1/2), C₂H₃N₃S·2C₄H₆O₄, (II), 2‐amino‐1,3,4‐thiadiazole–glutaric acid (1/1), C₂H₃N₃S·C₅H₈O₄, (III), and 2‐amino‐1,3,4‐thiadiazole–adipic acid (1/1), C₂H₃N₃S·C₆H₁₀O₄, (IV), are reported and their hydrogen‐bonding patterns are compared. The hydrogen bonds are of the types N—H...O or O—H...N and are of moderate strength. In some cases, weak C—H...O interactions are also present. Compound (II) differs from the others not only in the molar ratio of base and acid (1:2), but also in its hydrogen‐bonding pattern, which is based on chain motifs. In (I), (III) and (IV), the most prominent feature is the presence of an R₂²(8) graph‐set motif formed by N—H...O and O—H...N hydrogen bonds, which are present in all structures except for (I), where only a pair of N—H...O hydrogen bonds is present, in agreement with the greater acidity of oxalic acid. There are nonbonding S...O interactions present in all four structures. The difference electron‐density maps show a lack of electron density about the S atom along the S...O vector. In all four structures, the carboxylic acid H atoms are present in a rare configuration with a C—C—O—H torsion angle of ∼0°. In the structures of (II)–(IV), the C—C—O—H torsion angle of the second carboxylic acid group has the more common value of ∼|180|°. The dicarboxylic acid molecules are situated on crystallographic inversion centres in (II). The Raman and IR spectra of the title compounds are presented and analysed.     

Cocrystals of 6‐methyl‐2‐thiouracil: presence of the acceptor–donor–acceptor/donor–acceptor–donor synthon

The results of seven cocrystallization experiments of the antithyroid drug 6‐methyl‐2‐thiouracil (MTU), C₅H₆N₂OS, with 2,4‐diaminopyrimidine, 2,4,6‐triaminopyrimidine and 6‐amino‐3H‐isocytosine (viz. 2,6‐diamino‐3H‐pyrimidin‐4‐one) are reported. MTU features an ADA (A = acceptor and D = donor) hydrogen‐bonding site, while the three coformers show complementary DAD hydrogen‐bonding sites and therefore should be capable of forming an ADA/DAD N—H...O/N—H...N/N—H...S synthon with MTU. The experiments yielded one cocrystal and six cocrystal solvates, namely 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–1‐methylpyrrolidin‐2‐one (1/1/2), C₅H₆N₂OS·C₄H₆N₄·2C₅H₉NO, (I), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine (1/1), C₅H₆N₂OS·C₄H₆N₄, (II), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–N,N‐dimethylacetamide (2/1/2), 2C₅H₆N₂OS·C₄H₆N₄·2C₄H₉NO, (III), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–N,N‐dimethylformamide (2/1/2), C₅H₆N₂OS·0.5C₄H₆N₄·C₃H₇NO, (IV), 2,4,6‐triaminopyrimidinium 6‐methyl‐2‐thiouracilate–6‐methyl‐2‐thiouracil–N,N‐dimethylformamide (1/1/2), C₄H₈N₅⁺·C₅H₅N₂OS⁻·C₅H₆N₂OS·2C₃H₇NO, (V), 6‐methyl‐2‐thiouracil–6‐amino‐3H‐isocytosine–N,N‐dimethylformamide (1/1/1), C₅H₆N₂OS·C₄H₆N₄O·C₃H₇NO, (VI), and 6‐methyl‐2‐thiouracil–6‐amino‐3H‐isocytosine–dimethyl sulfoxide (1/1/1), C₅H₆N₂OS·C₄H₆N₄O·C₂H₆OS, (VII). Whereas in cocrystal (I) an R₂²(8) interaction similar to the Watson–Crick adenine/uracil base pair is formed and a two‐dimensional hydrogen‐bonding network is observed, the cocrystals (II)–(VII) contain the triply hydrogen‐bonded ADA/DAD N—H...O/N—H...N/N—H...S synthon and show a one‐dimensional hydrogen‐bonding network. Although 2,4‐diaminopyrimidine possesses only one DAD hydrogen‐bonding site, it is, due to orientational disorder, triply connected to two MTU molecules in (III) and (IV).     

4‐Pyridone–terephthalic acid–water (2/1/2) and bis(3‐hydroxypyridinium) terephthalate

4‐Hydroxypyridine and terephthalic acid cocrystallize as a hydrate, 4‐pyridone–terephthalic acid–water (2/1/2), 2C₅H₅NO·C₈H₆O₄·2H₂O, from a methanol–water solution. The molecules form a two‐dimensional hydrogen‐bonded network resulting in sheets of hydrogen‐bonded molecules that lie parallel to the (10) plane. In contrast, 3‐hydroxypyridine and terephthalic acid form the salt bis(3‐hydroxypyridinium) terephthalate, 2C₅H₆NO⁺·C₈H₄O₄²⁻, giving rise to two‐dimensional hydrogen‐bonded sheets extending through the lattice parallel to the (10) plane.     

One‐dimensional hydrogen‐bonded structures in the 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid with 8‐hydroxyquinoline, 8‐aminoquinoline and quinoline‐2‐carboxylic acid (quinaldic acid)

The structures of the 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid with 8‐hydroxyquinoline, 8‐aminoquinoline and quinoline‐2‐carboxylic acid (quinaldic acid), namely anhydrous 8‐hydroxyquinolinium 2‐carboxy‐4,5‐dichlorobenzoate, C₉H₈NO⁺·C₈H₃Cl₂O₄⁻, (I), 8‐aminoquinolinium 2‐carboxy‐4,5‐dichlorobenzoate, C₉H₉N₂⁺·C₈H₃Cl₂O₄⁻, (II), and the adduct hydrate 2‐carboxyquinolinium 2‐carboxy‐4,5‐dichlorobenzoate quinolinium‐2‐carboxylate monohydrate, C₁₀H₈NO₂⁺·C₈H₃Cl₂O₄⁻·C₁₀H₇NO₂·H₂O, (III), have been determined at 130 K. Compounds (I) and (II) are isomorphous and all three compounds have one‐dimensional hydrogen‐bonded chain structures, formed in (I) through O—H...O_carboxyl extensions and in (II) through N⁺—H...O_carboxyl extensions of cation–anion pairs. In (III), a hydrogen‐bonded cyclic R₂²(10) pseudo‐dimer unit comprising a protonated quinaldic acid cation and a zwitterionic quinaldic acid adduct molecule is found and is propagated through carboxylic acid O—H...O_carboxyl and water O—H...O_carboxyl interactions. In both (I) and (II), there are also cation–anion aromatic ring π–π associations. This work further illustrates the utility of both hydrogen phthalate anions and interactive‐group‐substituted quinoline cations in the formation of low‐dimensional hydrogen‐bonded structures.     

Tris(1,10‐phenanthroline‐κ2N,N′)iron(II) bis(2,4,5‐tricarboxybenzoate) monohydrate and tris(2,2′‐bipyridine‐κ2N,N′)iron(II) 2,5‐dicarboxybenzene‐1,4‐dicarboxylate–benzene‐1,2,4,5‐tetracarboxylic acid–water (1/1/2)

The title compounds, tris(1,10‐phenanthroline‐κ²N,N′)iron(II) bis(2,4,5‐tricarboxybenzoate) monohydrate, [Fe(C₁₂H₈N₂)₃](C₁₀H₅O₈)₂·H₂O, (I), and tris(2,2′‐bipyridine‐κ²N,N′)iron(II) 2,5‐dicarboxybenzene‐1,4‐dicarboxylate–benzene‐1,2,4,5‐tetracarboxylic acid–water (1/1/2), [Fe(C₁₀H₈N₂)₃](C₁₀H₄O₈)·C₁₀H₆O₈·2H₂O, (II), were obtained during an attempt to synthesize a mixed‐ligand complex of Fe^II with an N‐containing ligand and benzene‐1,2,4,5‐tetracarboxylic acid via a solvothermal reaction. In both mononuclear complexes, each Fe^II metal ion is six‐coordinated in a distorted octahedral manner by six N atoms from three chelating 1,10‐phenanthroline or 2,2′‐bipyridine ligands. In compound (I), the Fe^II atom lies on a twofold axis in the space group C2/c, whereas (II) crystallizes in the space group P2₁/n. In both compounds, the uncoordinated carboxylate anions and water molecules are linked by typical O—H...O hydrogen bonds, generating extensive three‐dimensional hydrogen‐bond networks which surround the cations.     

Four N7‐benzyl‐substituted 4,5,6,7‐tetrahydro‐1H‐pyrazolo[3,4‐b]pyridine‐5‐spiro‐1′‐cyclohexane‐2′,6′‐diones as ethanol hemisolvates: similar molecular constitutions but different crystal structures

3‐tert‐Butyl‐7‐(4‐chlorobenzyl)‐4′,4′‐dimethyl‐1‐phenyl‐4,5,6,7‐tetrahydro‐1H‐pyrazolo[3,4‐b]pyridine‐5‐spiro‐1′‐cyclohexane‐2′,6′‐dione ethanol hemisolvate, C₃₀H₃₄ClN₃O₂·0.5C₂H₆O, (I), its 7‐(4‐bromobenzyl)‐ analogue, C₃₀H₃₄BrN₃O₂·0.5C₂H₆O, (II), and its 7‐(4‐methylbenzyl)‐ analogue, C₃₁H₃₇N₃O₂·0.5C₂H₆O, (III), are isomorphous, with the ethanol component disordered across a twofold rotation axis in the space group C2/c. In the corresponding 7‐[4‐(trifluoromethyl)benzyl]‐ compound, C₃₁H₃₄F₃N₃O₂·0.5C₂H₆O, (IV), the ethanol component is disordered across a centre of inversion in the space group P. In each of (I)–(IV), the reduced pyridine ring adopts a half‐chair conformation. The heterocyclic components in (I)–(III) are linked into centrosymmetric dimers by a single C—H...π interaction, with the half‐occupancy ethanol component linked to the dimer by a combination of C—H...O and O—H...π(arene) hydrogen bonds. The heterocyclic molecules in (IV) are linked into chains of centrosymmetric rings by C—H...O and C—H...π hydrogen bonds, again with the half‐occupancy ethanol component pendent from the chain. The significance of this study lies in the isomorphism of the related derivatives (I)–(III), in the stoichiometric hemisolvation by ethanol, where the disordered solvent molecule is linked to the heterocyclic component by a two‐point linkage, and in the differences between the crystal structures of (I)–(III) and that of (IV).     

The ternary complex 4‐(2‐pyridyl)pyridinium–3,5‐di­nitro­benzoate–3,5‐di­nitro­benzoic acid (1/1/1)

In the title ternary complex, C₁₀H₉N₂⁺·C₇H₃N₂O₆^?·C₇H₄N₂O₆, the pyridinium cation adopts the role of the donor in an intermolecular N—H?O hydrogen‐bonding interaction with the carboxyl­ate group of the 3,5‐di­nitro­benzoate anion. The mol­ecules of the ternary complex form molecular ribbons perpendicular to the b direction, which are stabilized by one N—H?O, one O—H?O and five C—H?O intermolecular hydrogen bonds. The ribbons are further interconnected by three intermolecular C—H?O hydrogen bonds into a three‐dimensional network.     

4,4′‐Bipyridyl N,N′‐dioxide–3‐hydroxy‐2‐naphthoic acid (1/2)

4,4′‐Bipyridyl N,N′‐dioxide crystallizes with 3‐hydr­oxy‐2‐naphthoic acid to give a centrosymmetric three‐component adduct, C₁₀H₈N₂O₂·2C₁₁H₈O₃, which is engineered into a two‐dimensional layer structure by two kinds of π–π inter­actions. Weak C—H⋯O inter­actions further link the two‐dimensional structure into a three‐dimensional structure.     

2‐Pyridone–tartronic acid (1/1), 3‐hydroxy­pyridinium hydrogen tartronate and 4‐hydroxy­pyridinium hydrogen tartronate

Tartronic acid forms a hydrogen‐bonded complex, C₅H₅NO·C₃H₄O₅, (I), with 2‐pyridone, while it forms acid salts, namely 3‐hydroxy­pyridinium hydrogen tartronate, (II), and 4‐hy­droxy­pyridinium hydrogen tartronate, (III), both C₅H₆NO⁺·C₃H₃O₅⁻, with 3‐hydroxy­pyridine and 4‐hydroxy­pyridine, respectively. In (I), the pyridone mol­ecules and the acid mol­ecules form R(8) and R(10) hydrogen‐bonded rings, respectively, around the inversion centres. In (II) and (III), the cations and anions are linked by N—H⋯O and O—H⋯O hydrogen bonds to form a hydrogen‐bonded chain. In each of (I), (II) and (III), an intermolecular hydrogen bond is formed between a carboxyl group and the hydroxyl group attached to the central C atom, and in (I), the hydroxyl group participates in an intramolecular hydrogen bond with a carbonyl group. No intermolecular hydrogen bond is formed between the carboxyl groups in (I), or between the carboxyl and carboxyl­ate groups in (II) and (III).     

6‐Propyl‐2‐thiouracil versus 6‐methoxymethyl‐2‐thiouracil: enhancing the hydrogen‐bonded synthon motif by replacement of a methylene group with an O atom

The understanding of intermolecular interactions is a key objective of crystal engineering in order to exploit the derived knowledge for the rational design of new molecular solids with tailored physical and chemical properties. The tools and theories of crystal engineering are indispensable for the rational design of (pharmaceutical) cocrystals. The results of cocrystallization experiments of the antithyroid drug 6‐propyl‐2‐thiouracil (PTU) with 2,4‐diaminopyrimidine (DAPY), and of 6‐methoxymethyl‐2‐thiouracil (MOMTU) with DAPY and 2,4,6‐triaminopyrimidine (TAPY), respectively, are reported. PTU and MOMTU show a high structural similarity and differ only in the replacement of a methylene group (–CH₂–) with an O atom in the side chain, thus introducing an additional hydrogen‐bond acceptor in MOMTU. Both molecules contain an ADA hydrogen‐bonding site (A = acceptor and D = donor), while the coformers DAPY and TAPY both show complementary DAD sites and therefore should be capable of forming a mixed ADA/DAD synthon with each other, i.e. N—H…O, N—H…N and N—H…S hydrogen bonds. The experiments yielded one solvated cocrystal salt of PTU with DAPY, four different solvates of MOMTU, one ionic cocrystal of MOMTU with DAPY and one cocrystal salt of MOMTU with TAPY, namely 2,4‐diaminopyrimidinium 6‐propyl‐2‐thiouracilate–2,4‐diaminopyrimidine–N,N‐dimethylacetamide–water (1/1/1/1) (the systematic name for 6‐propyl‐2‐thiouracilate is 6‐oxo‐4‐propyl‐2‐sulfanylidene‐1,2,3,6‐tetrahydropyrimidin‐1‐ide), C₄H₇N₄⁺·C₇H₉N₂OS⁻·C₄H₆N₄·C₄H₉NO·H₂O, (I), 6‐methoxymethyl‐2‐thiouracil–N,N‐dimethylformamide (1/1), C₆H₈N₂O₂S·C₃H₇NO, (II), 6‐methoxymethyl‐2‐thiouracil–N,N‐dimethylacetamide (1/1), C₆H₈N₂O₂S·C₄H₉NO, (III), 6‐methoxymethyl‐2‐thiouracil–dimethyl sulfoxide (1/1), C₆H₈N₂O₂S·C₂H₆OS, (IV), 6‐methoxymethyl‐2‐thiouracil–1‐methylpyrrolidin‐2‐one (1/1), C₆H₈N₂O₂S·C₅H₉NO, (V), 2,4‐diaminopyrimidinium 6‐methoxymethyl‐2‐thiouracilate (the systematic name for 6‐methoxymethyl‐2‐thiouracilate is 4‐methoxymethyl‐6‐oxo‐2‐sulfanylidene‐1,2,3,6‐tetrahydropyrimidin‐1‐ide), C₄H₇N₄⁺·C₆H₇N₂O₂S⁻, (VI), and 2,4,6‐triaminopyrimidinium 6‐methoxymethyl‐2‐thiouracilate–6‐methoxymethyl‐2‐thiouracil (1/1), C₄H₈N₅⁺·C₆H₇N₂O₂S⁻·C₆H₈N₂O₂S, (VII). Whereas in (I) only an AA/DD hydrogen‐bonding interaction was formed, the structures of (VI) and (VII) both display the desired ADA/DAD synthon. Conformational studies on the side chains of PTU and MOMTU also revealed a significant deviation for cocrystals (VI) and (VII), leading to the desired enhancement of the hydrogen‐bond pattern within the crystal.     

2‐Aminopyridinium–succinate–succinic acid (2/1/1)

In the title compound, 2C₅H₇N₂⁺·C₄H₄O₄^2?·C₄H₆O₄, cyclic eight‐membered hydrogen‐bonded rings exist involving 2‐amino­pyridinium and succinate ions. The succinic acid and succinate moieties lie on inversion centres. Succinic acid mol­ecules and succinate ions are linked into zigzag chains by O—H?O hydrogen bonds, with O?O distances of 2.6005 (16) Å.     

Magnesium iodide–4,4′‐bipyridine–water (1/3/4) and strontium iodide–4,4′‐bipyridine–propan‐1‐ol (1/2.5/2)

Both of the title compounds, catena‐poly­[[[tetra­aqua­magnesium(I)]‐μ‐4,4′‐bi­pyridine‐κ²N:N′] diiodide bis(4,4′‐bi­pyridine) solvate], {[Mg(C₁₀H₈N₂)(H₂O)₄]I₂·2C₁₀H₈N₂}_n, (I), and catena‐poly­[[[μ‐4,4′‐bi­pyridine‐bis­[di­iodo­bis­(propan‐1‐ol)­strontium(I)]]‐di‐μ‐4,4′‐bi­pyridine‐κ⁴N:N′] bis(4,4′‐bi­pyri­dine) solvate], {[Sr₂I₄(C₁₀H₈N₂)₃(C₃H₈O)₄]·2C₁₀H₈N₂}_n, (II), are one‐dimensional polymers which are single‐ and double‐stranded, respectively, the metal atoms being linked by the 4,4′‐bi­pyridine moieties. The Mg complex, (I), is [cis‐{(H₂O)₄Mg(N‐4,4′‐bi­pyridine‐N′)_(2/2)}]_(∞|∞)I₂·4,4′‐bi­pyridine and Mg has a six‐coordinate quasi‐octahedral coordination environment. The Sr complex, (II), is isomorphous with its previously defined Ba counterpart [Kepert, Waters & White (1996). Aust. J. Chem. 49 , 117–135], being [(propan‐1‐ol)₂I₂Sr(N‐4,4′‐bi­pyridine‐N′)_(3/2)]_(∞|∞)·4,4′‐bi­pyridine, with the I atoms trans‐axial in a seven‐coordinate pentagonal–bipyramidal Sr environment.     

2‐Aminopyrimidine–3,3,3‐triphenylpropanoic acid (1/1)

The title bimolecular compound, C₄H₅N₃·C₂₁H₁₈O₂, constructed from 2‐aminopyrimidine and 3,3,3‐triphenylpropanoic acid, forms a tetramolecular hydrogen‐bonded motif via O—H...N, N—H...O and N—H...N contacts. This aggregate organizes to give crystal‐packing motifs with hydrophilic and hydrophobic regions.     

Supramolecular architectures in the salt trimethoprimium ferrocene‐1‐carboxylate and the cocrystal 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–ferrocene‐1‐carboxylic acid (1/1)

In the salt trimethoprimium ferrocenecarboxylate [systematic name: 2,4‐diamino‐5‐(3,4,5‐trimethoxybenzyl)pyrimidin‐1‐ium ferrocene‐1‐carboxylate], (C₁₄H₁₉N₄O₃)[Fe(C₅H₅)(C₆H₄O₂)], (I), of the antibacterial compound trimethoprim, the carboxylate group interacts with the protonated aminopyrimidine group of trimethoprim via two N—H…O hydrogen bonds, generating a robust R ₂²(8) ring motif (heterosynthon). However, in the cocrystal 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–ferrocene‐1‐carboxylic acid (1/1), [Fe(C₅H₅)(C₆H₅O₂)]·C₆H₈ClN₃, (II), the carboxyl–aminopyrimidine interaction [R ₂²(8) motif] is absent. The carboxyl group interacts with the pyrimidine ring via a single O—H…N hydrogen bond. The pyrimidine rings, however, form base pairs via a pair of N—H…N hydrogen bonds, generating an R ₂²(8) supramolecular homosynthon. In salt (I), the unsubstituted cyclopentadienyl ring is disordered over two positions, with a refined site‐occupation ratio of 0.573 (10):0.427 (10). In this study, the two five‐membered cyclopentadienyl (Cp) rings of ferrocene are in a staggered conformation, as is evident from the C…Cg …Cg …C pseudo‐torsion angles, which are in the range 36.13–37.53° for (I) and 22.58–23.46° for (II). Regarding the Cp ring of the minor component in salt (I), the geometry of the ferrocene ring is in an eclipsed conformation, as is evident from the C…Cg …Cg …C pseudo‐torsion angles, which are in the range 79.26–80.94°. Both crystal structures are further stabilized by weak π–π interactions.     

Hydrogen‐bonded zigzag chains in 2,2′‐dithiodibenzoic acid–1,3‐di‐4‐pyridylpropane (1/1)

The title 1:1 cocrystal, C₁₄H₁₀O₄S₂·C₁₃H₁₄N₂ or H₂L·bpp, has the two components connected by O—H...N hydrogen bonds to generate a one‐dimensional zigzag chain running along the crystallographic a direction. These chains are further stacked into a three‐dimensional supramolecular network by weak C—H...O and C—H...π contacts. Comparison of the structural differences with previous findings suggests that deprotonated forms, hydrogen‐bonding sites and flexible ligand conformations become significant factors that influence the topological arrangement and binding stoichiometry of the resulting cocrystals.     

Hydrated hexacyanometallate(III) salts of triaqua(18‐crown‐6)lanthanoid(III) and tetraaqua(18‐crown‐6)lanthanoid(III) cations containing nine‐ and ten‐coordinate lanthanoids

Tetraaqua(18‐crown‐6)cerium(III) hexacyanoferrate(III) dihydrate, [Ce(C₁₂H₂₄O₆)(H₂O)₄][Fe(CN)₆]·2H₂O, and tetraaqua(18‐crown‐6)neodymium(III) hexacyanoferrate(III) dihydrate, [Nd(C₁₂H₂₄O₆)(H₂O)₄][Fe(CN)₆]·2H₂O, are isomorphous and isostructural in the C2/c space group, where the cations, which contain ten‐coordinate lanthanoid centres, lie across twofold rotation axes and the anions lie across inversion centres. In these compounds, an extensive series of O—H...O and O—H...N hydrogen bonds links the components into a continuous three‐dimensional framework. Triaqua(18‐crown‐6)lanthanoid(III) hexacyanoferrate(III) dihydrate, [Ln(C₁₂H₂₄O₆)(H₂O)₃][Fe(CN)₆]·2H₂O, where Ln = Sm, Eu, Gd or Tb, are all isomorphous and isostructural in the P space group, as are triaqua(18‐crown‐6)gadolinium(III) hexacyanochromate(III) dihydrate, [Gd(C₁₂H₂₄O₆)(H₂O)₃][Cr(CN)₆]·2H₂O, and triaqua(18‐crown‐6)gadolinium(III) hexacyanocobaltate(III) dihydrate, [Gd(C₁₂H₂₄O₆)(H₂O)₃][Co(CN)₆]·2H₂O. In these compounds, there are two independent anions, both lying across inversion centres, and the lanthanoid centres exhibit nine‐coordination; in the crystal structures, an extensive series of hydrogen bonds links the components into a three‐dimensional framework.     

The hydrogen‐bonded complex bis(tert‐butylammonium) 2,6‐dichlorophenolate 2,4‐dichlorophenol–2,4‐dichlorophenolate tetrahydrofuran disolvate containing a chiral R53(10) hydrogen‐bonded ring as a supramolecular synthon

A fixed hydrogen‐bonding motif with a high probability of occurring when appropriate functional groups are involved is described as a `supramolecular hydrogen‐bonding synthon'. The identification of these synthons may enable the prediction of accurate crystal structures. The rare chiral hydrogen‐bonding motif R₅³(10) was observed previously in a cocrystal of 2,4,6‐trichlorophenol, 2,4‐dichlorophenol and dicyclohexylamine. In the title solvated salt, 2C₄H₁₂N⁺·C₆H₃Cl₂O⁻·(C₆H₃Cl₂O⁻·C₆H₄Cl₂O)·2C₄H₈O, five components, namely two tert‐butylammonium cations, one 2,4‐dichlorophenol molecule, one 2,4‐dichlorophenolate anion and one 2,6‐dichlorophenolate anion, are bound by N—H…O and O—H…O hydrogen bonds to form a hydrogen‐bonded ring, with the graph‐set motif R₅³(10), which is further associated with two pendant tetrahydrofuran molecules by N—H…O hydrogen bonds. The hydrogen‐bonded ring has internal symmetry, with a twofold axis running through the centre of the 2,6‐dichlorophenolate anion, and is isostructural with a previous and related structure formed from 2,4‐dichlorophenol, dicyclohexylamine and 2,4,6‐trichlorophenol. In the title crystal, helical columns are built by the alignment and twisting of the chiral hydrogen‐bonded rings, along and across the c axis, and successive pairs of rings are associated with each other through C—H…π interactions. Neighbouring helical columns are inversely related and, therefore, no chirality is sustained, in contrast to the previous case.     

The acid adducts hydrazinium 2‐hydroxybenzoate–2‐hydroxybenzoic acid (1/1) and hydrazinium 3‐hydroxy‐2‐naphthoate–3‐hydroxy‐2‐naphthoic acid (1/1)

The title molecular salts, N₂H₅⁺·C₇H₅O₃⁻·C₇H₆O₃ and N₂H₅⁺·C₁₁H₇O₃⁻·C₁₁H₈O₃, are acid adducts containing a hydrazinium cation, one molecule of a deprotonated acid and one molecule of a neutral acid. The two compounds contain essentially identical hydrogen‐bond networks between the hydrazinium cation and the acid molecules, which define closely comparable two‐dimensional layers in the structures. The planes of the aromatic rings within both structures are approximately parallel and the layers are stacked with comparable intermolecular interactions.     

Two phosphonodehydrotripeptides: Boc0–Gly1–Δ(Z)Phe2–α‐Abu3PO3Me2 and Boc0–Gly1–Δ(Z)Phe2–α‐Nva3PO3Et2

The present paper reports the crystal structures of two short phosphonotripeptides (one in two crystal forms) containing one ΔPhe (dehydrophenylalanine) residue, namely dimethyl (3‐{[tert‐butoxycarbonylglycyl‐α,β‐(Z)‐dehydrophenylalanyl]amino}propyl)phosphonate, Boc⁰–Gly¹–Δ(Z)Phe²–α‐Abu³PO₃Me₂, C₂₁H₃₂N₃O₇P, (I), and diethyl (4‐{[tert‐butoxycarbonylglycyl‐α,β‐(Z)‐dehydrophenylalanyl]amino}butyl)phosphonate, Boc⁰–Gly¹–Δ(Z)Phe²–α‐Nva³PO₃Et₂, as the propan‐2‐ol monosolvate 0.122‐hydrate, C₂₄H₃₈N₃O₇P·C₃H₈O·0.122H₂O, (II), and the ethanol monosolvate 0.076‐hydrate, C₂₄H₃₈N₃O₇P·C₂H₆O·0.076H₂O, (III). The crystals of (II) and (III) are isomorphous but differ in the type of solvent. The phosphono group is linked directly to the last C_α atom in the main chain for all three peptides. All the amino acids are trans linked in the main chains. The crystal structures exhibit no intramolecular hydrogen bonds and are stabilized by intermolecular hydrogen bonds only.